Reuters |
EU approves Sanofi and Regeneron's dupilumab in eczema
Reuters The move comes after the U.S Food and Drug Administration (FDA) regulator had also approved the injectable antibody drug in March. The product is sold as Dupixent. Atopic dermatitis is a chronic type of skin inflammation also known as eczema, which in … Sanofi's Dupixent gets Europe eczema nod Sanofi, Regeneron claim EU approval for eczema drug Dupixent Regeneron and Sanofi Announce Approval of DUPIXENT® (dupilumab) to Treat Adult Patients with Moderate-to … |